Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Taxes |
|
| Schedule of components of income tax expense |
| | | | | | | | | Year Ended December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | (Loss)/profit before tax | | | | | | | (Loss)/profit from PRC entities | | (71,249) | | (20,596) | | 32,088 | Profit from overseas entities | | 14,183 | | 27,738 | | 27,755 | Total (loss)/profit before tax | | (57,066) | | 7,142 | | 59,843 |
| | | | | | | | | Year Ended December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | Current income tax expense | | 3,249 | | 2,145 | | 1,953 | Deferred income tax | | — | | — | | — | Total income tax expense | | 3,249 | | 2,145 | | 1,953 |
|
| Schedule of reconciliation of differences between statutory tax rate and effective tax rate |
| | | | | | | | Year Ended December 31, 2025 | | | | Amount | | Percent | | | | | | | | PRC Statutory income tax rate | | 14,961 | | 25.0 | % | Foreign Tax Effects | | | | | | Hong Kong | | | | | | Statutory tax rates in difference between PRC and Hong Kong | | (2,497) | | (4.2) | % | Permanent book-tax differences | | (6,840) | | (11.4) | % | Change in valuation allowance | | 1,532 | | 2.6 | % | Other | | 457 | | 0.8 | % | Other foreign jurisdictions | | 406 | | 0.7 | % | Tax Credits | | | | | | Effect of preferential tax rate for qualified HNTE entities (1) | | (2,936) | | (4.9) | % | Additional deduction for research and development expenditures | | (4,469) | | (7.5) | % | Non-taxable or non-deductible Items | | | | | | Share-based compensation | | 866 | | 1.4 | % | Permanent book-tax differences | | 9,861 | | 16.5 | % | Change in Valuation Allowance (2) | | (11,331) | | (18.9) | % | PRC withholding income tax on interest income and investment income | | 1,943 | | 3.2 | % | Effective Tax Rates | | 1,953 | | 3.3 | % |
| | | | | | | | Year Ended December 31, | | | | 2023 | | 2024 | | PRC Statutory income tax rate | | 25.0 | % | 25.0 | % | Effect of tax rates in different tax jurisdiction | | (2.5) | % | (35.1) | % | Effect of preferential tax rate for qualified HNTE entities (1) | | (5.4) | % | (8.6) | % | Additional deduction for research and development expenditures | | 9.3 | % | (62.8) | % | Share-based compensation | | (19.7) | % | 141.2 | % | Permanent book-tax differences | | 2.0 | % | (13.3) | % | Change in valuation allowance | | (14.4) | % | (16.4) | % | Effective Tax Rates | | (5.7) | % | 30.0 | % |
| (1) | The effect of the preferential income tax rate that the WFOE is entitled to enjoy as a qualified HNTE is 15%. |
| (2) | Valuation allowance for the years ended December 31, 2023, 2024 and 2025 are related to the deferred tax assets of certain group entities which reported losses. The Group believes that it is more likely than not that the deferred tax assets of these entities will not be utilized. Therefore, valuation allowance has been provided. |
|
| Schedule of income tax disclosures |
| | | | | US$ | | | | Chinese mainland | | 2,517 | Non-Chinese mainland | | 17 | Total cash paid for income taxes, net of refunds | | 2,534 |
|
| Summary of deferred tax assets and deferred tax liabilities |
| | | | | | | | | | | | | | | | As of December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | Deferred tax assets | | | | | | | Net accumulated losses carry-forwards | | 107,080 | | 104,089 | | 95,110 | Credit-related impairment of long-term investments | | 1,421 | | 1,472 | | 1,482 | Receivables allowances | | 279 | | 795 | | 696 | Inventory write-downs | | 531 | | 845 | | 547 | Other deductible temporary difference | | 106 | | 1,046 | | 840 | Less: valuation allowance | | (109,417) | | (108,247) | | (98,675) | Total deferred tax assets | | — | | — | | — |
|
| Summary of tax losses carry forwarded for future years |
| | | As of December 31, 2025 | | US$ | 2026 | | 101,317 | 2027 | | 42,159 | 2028 | | 35,464 | 2029 | | 91,815 | 2030 | | 55,663 | 2031 | | 34,073 | 2032 | | 60,506 | 2033 | | 10,896 | Total tax losses carry forwards | | 431,893 |
|
| Schedule of movement of valuation allowance |
| | | | | | | | | As of December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | Balance at beginning of the year | | 101,177 | | 109,417 | | 108,247 | Changes of valuation allowance(1) | | 8,240 | | (1,170) | | (9,572) | Balance at end of the year | | 109,417 | | 108,247 | | 98,675 |
| (1) | Valuation allowances have been provided against deferred tax assets when the Group determines that it is more likely than not that the deferred tax assets will not be utilized in the future. In making such determination, the Group evaluates a variety of factors including the Group’s entities’ operating history, accumulated deficit, existence of taxable temporary differences and reversal periods. As of December 31, 2024 and 2025, full valuation allowances on deferred tax assets were provided because it was more likely than not that the Group will not be able to utilize tax loss carry forwards and other temporary tax difference generated by its unprofitable subsidiaries. |
|